e-learning
resources
Milan 2017
Sunday, 10.09.2017
Towards better treatments for lung disease: experimental pharmacology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma.
E. Kogut (Warszawa, Poland)
Source:
International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Session:
Towards better treatments for lung disease: experimental pharmacology
Session type:
Thematic Poster
Number:
1047
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Kogut (Warszawa, Poland). Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma.. 1047
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Gender effect on airway and lung parenchyma remodelling in an experimental model of chronic allergic asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
IL-13-dependent C3a-release in a murine model of allergic asthma
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005
ST2 gene knockout attenuates allergic airways disease
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
Models of asthma employing ovalbumin in rats and mice: similarities and differences compared with patient asthma
Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Year: 2005
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Development of a mouse model of airway inflammation and remodeling in experimental asthma
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003
A 4-week model of allergic airways inflammation that exhibits the 3 salient features of asthma.
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Alamandine reduces eosinophilic inflammation in an experimental model of asthma
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Characterisation of type two immune responses in a murine model of allergic airway disease
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
Mast cell myositis is associated with airway remodelling in a chronic model of murine asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 226s
Year: 2006
Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007
Comparison of the inflammatory response between two chronic models of allergic lung inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 368s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept